Piotr Kuna

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Jan Brożek, Jean Bousquet, Ioana Agache et al. · Journal of Allergy and Clinical Immunology · 2017 · 1.9K citations · Full text

Asthma, Allergy, Allergy Medicine +5

Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

Parameswaran Nair, Sally E. Wenzel, Klaus F. Rabe et al. · New England Journal of Medicine · 2017 · 1K citations · Full text

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Jean Bousquet, Holger J. Schünemann, Bolesław Samoliński et al. · Journal of Allergy and Clinical Immunology · 2012 · 628 citations · Full text

Asthma, Allergy, Allergy Medicine +5

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy

Allen P. Kaplan, Dennis K. Ledford, Mark Ashby et al. · Journal of Allergy and Clinical Immunology · 2013 · 552 citations

Symptomatic Chronic, Allergy Medicine, Clinical Dermatology +5

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

Mario Castro, Sally E. Wenzel, Eugene R. Bleecker et al. · The Lancet Respiratory Medicine · 2014 · 480 citations

Asthma, Rheumatology, Allergy +10